Macquarie's 1st Half Profit Falls, Announces A$2 Billion Buyback
By Alice Uribe
SYDNEY--Macquarie Group's first-half net profit fell by 39%, but the company said its strong capital position means it could soon begin buying back shares worth up to 2 billion Australian dollars (US$1.29 billion).
Macquarie, Australia's biggest investment bank and asset manager, said its net profit for the six months through September fell to 1.42 billion Australian dollars (US$910 million), from A$2.31 billion a year ago.
"Our annuity-style businesses saw growth in loan books, deposits and assets under management, but the first-half result was substantially down compared to a strong period of realizations in the prior corresponding period," said Chief Executive Shemara Wikramanayake. "Our markets-facing businesses delivered solid performances despite lower market activity and volatility level."
For the fiscal first half, Macquarie's annuity-style activities contributed A$1.3 billion to net profit, although this down 43% on a year earlier.
The company's annuity-style activities cover Macquarie Asset Management, Banking and Financial Services and certain businesses in Commodities and Global Markets. Markets-facing activities for the first half were down 32% on year at A$1.56 billion.
Markets-facing activities are undertaken by Macquarie Capital and most businesses in CGM.
Directors of the company declared an interim dividend of A$2.55 per share, compared with A$3.00 a year ago. That beat under consensus forecasts compiled by FactSet, which projected Macquarie's interim dividend would be A$2.42.
Macquarie, which has a reputation among analysts for conservative forecasts, didn't provide specific guidance.
Write to Alice Uribe at alice.uribe@wsj.com
(END) Dow Jones Newswires
November 02, 2023 17:53 ET (21:53 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track